Still has a while, but FDA granted orphan drug status which grants exclusivity for 7 years. Kinda like extra patent protection. In Phase I testing now, then Phase II & II, then approval.
Looks very promising.
And yes, I do work in the pharma industry (for a different company, not SIRT).